Table 2.

Clinical outcomes according to different SHR tertiles

	SHR1 (≤ 0.73) N = 143	SHR2 (0.73–0.84) N = 131	SHR3 (≥ 0.84) N = 136	P value
MACE, n (%)	22 (15.4)	22 (16.8)	48 (35.3)	< 0.001
Cardiac death, n (%)	7 (4.9)	4 (3.1)	12 (8.8)	0.110
Non-fatal MI, n (%)	1 (0.7)	1 (0.8)	2 (1.5)	0.771
Heart failure, n (%)	3 (2.1)	4 (3.1)	8 (5.9)	0.220
Angina rehospitalization, n (%)	10 (7.0)	13 (9.9)	22 (16.2)	0.044
Stroke, n (%)	1 (0.7)	0	4 (2.9)	0.071

MACE major adverse cardiac events, MI acute myocardial infarction, SHR stress hyperglycemia ratio